WHO Drug Information - Volume 35, No. 3

Overview

The third issue of Volume 35, includes

Consultation Documents:

• WHO Biowaiver Project – Preparation for Cycle V (2022): Prioritization Exercise of Active Pharmaceutical Ingredients on the WHO Model List of Essential Medicines for Solubility Determination and Biopharmaceutics Classification System-Based Classification
  
• IAEA/WHO Guideline on Good Manufacturing Practices for Investigational Radiopharmaceutical Products
  
• WHO Good Practices for Research and Development Facilities of Pharmaceutical Products
  
• WHO Good Manufacturing Practices for Investigational Products
  
• Dolutegravir Dispersible Tablets (dolutegraviri compressi dispersibili)
  
• Benzathine benzylpenicillin tetrahydrate (benzathini benzylpenicillinum tetrahydricum)
  
• Benzathine benzylpenicillin for injection (benzathini benzylpenicillini ad injectionem)
  

Issue 3 concludes with List No. 86 of Recommended International Nonproprietary Names (INN) for Pharmaceutical Substances